Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Noevir Holdings Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was 円46,318 Mil. Noevir Holdings Co's Total Assets for the quarter that ended in Dec. 2023 was 円71,745 Mil.
Therefore, Noevir Holdings Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.65.
The historical rank and industry rank for Noevir Holdings Co's Equity-to-Asset or its related term are showing as below:
TSE:4928'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.57 Med: 0.62 Max: 0.68
Current: 0.65
During the past 13 years, the highest Equity to Asset Ratio of Noevir Holdings Co was 0.68. The lowest was 0.57. And the median was 0.62.
TSE:4928's Equity-to-Asset is ranked better than 66.32% of 1918
companies
in the Consumer Packaged Goods industry
Industry Median: 0.54
vs TSE:4928: 0.65
Noevir Holdings Co Equity-to-Asset Historical Data
The historical data trend for Noevir Holdings Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Noevir Holdings Co's Equity-to-Asset
For the Household & Personal Products subindustry, Noevir Holdings Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noevir Holdings Co's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Noevir Holdings Co's Equity-to-Asset falls into.
Noevir Holdings Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Noevir Holdings Co's Equity to Asset Ratio for the fiscal year that ended in Sep. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noevir Holdings Co (TSE:4928) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Noevir Holdings Co Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Noevir Holdings Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Noevir Holdings Co (TSE:4928) Business Description
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4928 has been successfully added to your 